Sign in to view content

Percentage of Patients Maintained on Quarterly Anti-VEGF Dosing for the Treatment of Neovascular Age-Related Macular Degeneration Across Key Clinical Trials

David A. Eichenbaum, MD, FASRS

Video
Published 2018

Related

Canadian Treat-and-Extend Analysis Trial With Ranibizumab in Patients With Neovascular AMD: CANTREAT Study 1-Year Results
Peter J. Kertes, MD, FRCS(C)
Annual Meeting Talks
2018
Vision-Related Functioning in Patients Undergoing Pneumatic Retinopexy Versus Vitrectomy for Primary Retinal Detachment: Subanalysis of the PIVOT Trial
Carolina Lampert Monte Francisconi, MD
Annual Meeting Talks
2018
E27- DRCR Protocol V Results- Anti-VEGF vs Focal Laser vs Observation for DME in Eyes with Very Good Vision- Dr. Jennifer Sun
Keyvan Koushan, MD, FRCSC
Member Podcasts

Category: Age-Related Macular Degeneration

See more